세계의 치료제 시장(2024년판) : 분자 유형별, 치료 영역별, 지역별, 국가별 분석, 시장 인사이트 및 예측(2020-2030년)

Executive Summary

Azoth Analytics has released a research report titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, Cardiovascular Disease, Diabetes/Obesity, Immunology, Other Therapeutic Areas) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Therapeutics market showcased growth at a CAGR of 6.61% during 2020-2023. The market was valued at USD 686.97 Billion in 2023 which is expected to reach USD 1115.90 Billion in 2030.

Chronic diseases like cancer, heart disease, diabetes, and neurological disorders are fueling the global therapeutics market. The World Health Organization (WHO) reports these conditions as the leading cause of death and disability, accounting for over 70% of all deaths. This rise is attributed to factors like an aging population, unhealthy lifestyles, and environmental pollution.

Furthermore, the rapidly aging population, with the number of people over 60 expected to reach 2 billion by 2050, creates a growing demand for treatments for age-related conditions like Alzheimer's, dementia, and osteoporosis. Additionally, the elderly are more prone to multiple chronic conditions, necessitating the development of combination therapies and effective management strategies.

Looking ahead, the global therapeutics market is poised for continued growth due to the increasing focus on innovation, personalized medicine, and cost-effectiveness, creating new opportunities for market players. Additionally, the growing threat of antibiotic resistance underscores the need for novel antimicrobial therapies.

Scope of the Report:

• The report analyses the Therapeutics Market by Value (USD Billion).
• The report analyses the Therapeutics Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
• The report presents the analysis of Therapeutics Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Therapeutics Market By Molecule Type (Biologics and Biosimilars, Small Molecules)
• The report analyses the Therapeutics Market By Therapeutic Area (Oncology, Infectious Disease, and Cardiovascular Disease, Diabetes/Obesity, Immunology, and Other Therapeutic Areas).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Molecule Type and By Therapeutic Areas.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Analyst Recommendations

• 2.1 Personalized Medicine
• 2.2 Targeted therapy with Nanomedicine

3. Global Therapeutics Market: Historic and Forecast

• 3.1 Impact Analysis of Macro Economic Factors on Therapeutics Market
• 3.2 Global biotech spending
• 3.3 Pharmaceutical R&D expenditure in Europe, USA, Japan and China
• 3.4 Total Active API DMFs, by country
• 3.5 Top 10 Generic Products with Greatest Savings in 2022
• 3.6 Global Therapeutics Market: Dashboard
• 3.7 Global Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 3.8 Global Therapeutics Market: Market Value Assessment
• 3.9 Assessment Degree of Impact of COVID-19 on Therapeutics Market
• 3.10 Global Therapeutics Market Segmentation: By Molecule Type
  • 3.10.1 Global Therapeutics Market, By Molecule Type Overview
  • 3.10.2 Global Therapeutics Market Attractiveness Index, By Molecule Type
  • 3.10.3 Global Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10.4 Global Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
• 3.11 Global Therapeutics Market Segmentation: By Therapeutic Area
  • 3.11.1 Global Therapeutics Market, By Therapeutic Area Overview
  • 3.11.2 Global Therapeutics Market Attractiveness Index, By Therapeutic Area
  • 3.11.3 Global Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11.4 Global Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11.5 Global Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11.6 Global Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11.7 Global Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.11.8 Global Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Therapeutics Market, Region Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Therapeutics Market: Historic and Forecast

• 5.1 Americas Therapeutics Market: Snapshot
• 5.2 Americas Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 5.3 Americas Therapeutics Market: Key Factors
• 5.4 Americas Therapeutics Market: Segment Analysis
• 5.5 Americas Therapeutics Market Segmentation: By Molecule Type
  • 5.5.1 Americas Therapeutics Market, By Molecule Type Overview
  • 5.5.2 Americas Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.5.3 Americas Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.6 Americas Therapeutics Market Segmentation: Therapeutic Area
  • 5.6.1 Americas Therapeutics Market, By Therapeutic Area Overview
  • 5.6.2 Americas Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.3 Americas Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.4 Americas Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.5 Americas Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.6 Americas Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.7 Americas Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.7 Americas Therapeutics Market Segmentation: By Country
  • 5.7.1 Americas Therapeutics Market, by Country Overview
  • 5.7.2 United States Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.7.2.1 United States Therapeutics Market, By Molecule Type
    • 5.7.2.2 United States Therapeutics Market, By Therapeutic Area
  • 5.7.3 Canada Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.7.3.1 Canada Therapeutics Market, By Molecule Type
    • 5.7.3.2 Canada Therapeutics Market, By Therapeutic Area
  • 5.7.4 Rest of Americas Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.7.4.1 Rest of Americas Therapeutics Market, By Molecule Type
    • 5.7.4.2 Rest of Americas Therapeutics Market, By Therapeutic Area

6. Europe Therapeutics Market: Historic and Forecast

• 6.1 Europe Therapeutics Market: Snapshot
• 6.2 Europe Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 6.3 Europe Therapeutics Market: Key Factors
• 6.4 Europe Therapeutics Market: Segment Analysis
• 6.5 Europe Therapeutics Market Segmentation: By Molecule Type
  • 6.5.1 Europe Therapeutics Market, By Molecule Type Overview
  • 6.5.2 Europe Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.5.3 Europe Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.6 Europe Therapeutics Market Segmentation: By Therapeutic Area
  • 6.6.1 Europe Therapeutics Market, By Therapeutic Area Overview
  • 6.6.2 Europe Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.3 Europe Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.4 Europe Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.5 Europe Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.6 Europe Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.7 Europe Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.7 Europe Therapeutics Market Segmentation: By Country
  • 6.7.1 Europe Therapeutics Market, by Country Overview
  • 6.7.2 Germany Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.7.2.1 Germany Therapeutics Market, By Molecule Type
    • 6.7.2.2 Germany Therapeutics Market, By Therapeutic Area
  • 6.7.3 United Kingdom Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.7.3.1 United Kingdom Therapeutics Market, By Molecule Type
    • 6.7.3.2 United Kingdom Therapeutics Market, By Therapeutic Area
  • 6.7.4 France Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.7.4.1 France Therapeutics Market, By Molecule Type
    • 6.7.4.2 France Therapeutics Market, By Therapeutic Area
  • 6.7.5 Italy Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.7.5.1 Italy Therapeutics Market, By Molecule Type
    • 6.7.5.2 Italy Therapeutics Market, By Therapeutic Area
  • 6.7.6 Spain Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.7.6.1 Spain Therapeutics Market, By Molecule Type
    • 6.7.6.2 Spain Therapeutics Market, By Therapeutic Area
  • 6.7.7 Rest of Europe Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.7.7.1 Rest of Europe Therapeutics Market, By Molecule Type
    • 6.7.7.2 Rest of Europe Therapeutics Market, By Therapeutic Area

7. Asia Pacific Therapeutics Market: Historic and Forecast

• 7.1 Asia Pacific Therapeutics Market: Snapshot
• 7.2 Asia Pacific Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 7.3 Asia Pacific Therapeutics Market: Key Factors
• 7.4 Asia Pacific Therapeutics Market: Segment Analysis
• 7.5 Asia Pacific Therapeutics Market Segmentation: By Molecule Type
  • 7.5.1 Asia Pacific Therapeutics Market, By Molecule Type Overview
  • 7.5.2 Asia Pacific Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.5.3 Asia Pacific Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.6 Asia Pacific Therapeutics Market Segmentation: By Therapeutic Area
  • 7.6.1 Asia Pacific Therapeutics Market, By Therapeutic Area Overview
  • 7.6.2 Asia Pacific Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.4 Asia Pacific Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.5 Asia Pacific Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.6 Asia Pacific Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.7 Asia Pacific Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.7 Asia Pacific Therapeutics Market Segmentation: By Country
  • 7.7.1 Asia Pacific Therapeutics Market, by Country Overview
  • 7.7.2 China Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.7.2.1 China Therapeutics Market, By Molecule Type
    • 7.7.2.2 China Therapeutics Market, By Therapeutic Area
  • 7.7.3 Japan Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.7.3.1 Japan Therapeutics Market, By Molecule Type
    • 7.7.3.2 Japan Therapeutics Market, By Therapeutic Area
  • 7.7.4 India Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.7.4.1 India Therapeutics Market, By Molecule Type
    • 7.7.4.2 India Therapeutics Market, By Therapeutic Area
  • 7.7.5 Rest of Asia Pacific Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.7.5.1 Rest of Asia Pacific Therapeutics Market, By Molecule Type
    • 7.7.5.2 Rest of Asia Pacific Therapeutics Market, By Therapeutic Area

8. Middle East and Africa Therapeutics Market: Historic and Forecast

• 8.1 Middle East and Africa Therapeutics Market: Snapshot
• 8.2 Middle East and Africa Therapeutics Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 8.3 Middle East and Africa Therapeutics Market: Key Factors
• 8.4 Middle East and Africa Therapeutics Market: Segment Analysis
• 8.5 Middle East and Africa Therapeutics Market Segmentation: By Molecule Type
  • 8.5.1 Middle East and Africa Therapeutics Market, By Molecule Type Overview
  • 8.5.2 Middle East and Africa Therapeutics Market Size, By Biologics and Biosimilars, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.5.3 Middle East and Africa Therapeutics Market Size, By Small Molecules, By Value, 2020H-2030F (USD Billion & CAGR)
• 8.6 Middle East and Africa Therapeutics Market Segmentation: By Therapeutic Area
  • 8.6.1 Middle East and Africa Therapeutics Market, By Therapeutic Area Overview
  • 8.6.2 Middle East and Africa Therapeutics Market Size, By Oncology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Therapeutics Market Size, By Infectious Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.4 Middle East and Africa Therapeutics Market Size, By Cardiovascular Disease, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.5 Middle East and Africa Therapeutics Market Size, By Diabetes/Obesity, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.6 Middle East and Africa Therapeutics Market Size, By Immunology, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.7 Middle East and Africa Therapeutics Market Size, By Other Therapeutic Areas, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact assessment of Market Dynamics on Therapeutics Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Industry Ecosystem Analysis

• 10.1 Porter Analysis

11. Competitive Positioning

• 11.1 Companies Product Positioning
• 11.2 Market Position Matrix
• 11.3 Market Share Analysis of Therapeutics Market
• 11.4 Company Profiles
  • 11.4.1 Sanofi
  • 11.4.2 Cipla
  • 11.4.3 Pfizer
  • 11.4.4 GSK PLC
  • 11.4.5 Novartis AG
  • 11.4.6 Bayer AG
  • 11.4.7 Merck & Co., Inc.
  • 11.4.8 F. Hoffmann-La Roche AG
  • 11.4.9 Abbott Laboratories
  • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer